Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 7,324,437 $ 17,002,715
Investments 36,902,563 42,194,296
Restricted cash 192,475 192,475
Prepaid expenses and other current assets 1,445,524 791,616
Total current assets 45,864,999 60,181,102
Restricted cash 477,425 477,425
Property and equipment, net 1,431,945 1,613,815
Operating lease right of use assets 3,688,468 3,884,252
Other assets 182,436 155,346
Total assets 51,645,273 66,311,940
Current liabilities:    
Notes payable 203,258 353,323
Accounts payable 1,322,990 2,173,963
Accrued expenses 6,468,302 5,999,252
Derivative liability 36,868 36,868
Operating lease liabilities, current 1,318,671 1,280,863
Current portion of long-term debt 5,008,858 2,795,669
Total current liabilities 14,358,947 12,639,938
Long-term debt, net of debt discount 13,972,360 15,984,426
Other long-term liabilities 2,522,205 22,205
Operating lease liabilities, noncurrent 4,332,809 4,675,354
Total liabilities 35,186,321 33,321,923
Stockholders' equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding at March 31, 2023 and December 31, 2022. See Note 11 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized, 4,215,133 and 4,171,297 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 422 417
Additional paid-in capital 426,352,478 425,196,359
Accumulated deficit (409,825,479) (392,080,667)
Accumulated other comprehensive loss (68,469) (126,092)
Total stockholders’ equity 16,458,952 32,990,017
Total liabilities and stockholders’ equity $ 51,645,273 $ 66,311,940